The Gross Margin of Karyopharm Therapeutics Inc (KPTI) is 95.86%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 95.86% |
| 2023-12-31 | 96.62% |
| 2022-12-31 | 96.69% |
| 2021-12-31 | 98.38% |
| 2020-12-31 | 97.50% |
| 2019-12-31 | 94.13% |
| 2018-12-31 | 94.13% |